• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOPERVISION INC. BIOFINITY TORIC CONTACT LENS; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOPERVISION INC. BIOFINITY TORIC CONTACT LENS; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem Corneal Ulcer (1796)
Event Date 05/03/2018
Event Type  Injury  
Event Description
Habitual sleeping in prescription contact lenses, which were not approved for such use, caused a corneal ulcer in his left eye.Scars indicate this is not the first event this patient has experienced.Initiated treatment with maxitrol suspension, and patient must return for follow-up in four days before i can approve wear of contact lenses again.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFINITY TORIC CONTACT LENS
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
COOPERVISION INC.
MDR Report Key7494051
MDR Text Key107800735
Report NumberMW5077047
Device Sequence Number0
Product Code LPM
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2018
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age36 YR
-
-